Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neary

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
The Oncologist|January 5, 2019
Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review StudyMatthew H Kulke, Al B Benson, Arvind Dasari, et al.
The Oncologist|January 6, 2019
Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review StudyArvind Dasari, Emily K Bergsland, Al B Benson, et al.
BJU International|October 30, 2009
Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart reviewToni K Choueiri, Mei Sheng Duh, Jessica Clement, et al.
Pituitary|March 10, 2017
Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary cliniciansEliza B Geer, Alejandro Ayala, Vivien Bonert, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 15, 2017
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDYEliza B Geer, Ismat Shafiq, Murray B Gordon, et al.
The Lancet. Oncology|August 26, 2017
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialMarianne E Pavel, Simron Singh, Jonathan R Strosberg, et al.
International Journal of Oncology|November 20, 2013
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart reviewWilliam K Oh, David McDermott, Camillo Porta, et al.
Comprehensive Psychiatry|February 9, 2025
Mental health disorder symptom changes among public safety personnel after emotional resilience skills trainingR N Carleton, S Sauer-Zavala, T A Teckchandani, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
The Oncologist|January 5, 2019
Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review StudyMatthew H Kulke, Al B Benson, Arvind Dasari, et al.
The Oncologist|January 6, 2019
Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review StudyArvind Dasari, Emily K Bergsland, Al B Benson, et al.
BJU International|October 30, 2009
Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart reviewToni K Choueiri, Mei Sheng Duh, Jessica Clement, et al.
Pituitary|March 10, 2017
Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary cliniciansEliza B Geer, Alejandro Ayala, Vivien Bonert, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 15, 2017
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDYEliza B Geer, Ismat Shafiq, Murray B Gordon, et al.
The Lancet. Oncology|August 26, 2017
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialMarianne E Pavel, Simron Singh, Jonathan R Strosberg, et al.
International Journal of Oncology|November 20, 2013
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart reviewWilliam K Oh, David McDermott, Camillo Porta, et al.
Comprehensive Psychiatry|February 9, 2025
Mental health disorder symptom changes among public safety personnel after emotional resilience skills trainingR N Carleton, S Sauer-Zavala, T A Teckchandani, et al.
Pageof 15